Skip to main

ASGCT Foundation

By addressing resource scarcity and systemic barriers, we are bridging the gap between scientific discovery and patient delivery.

Breaking Down Barriers to Life-Changing Therapies

The ASGCT Foundation is a charitable nonprofit organization dedicated to ensuring that the life-changing potential of gene and cell therapy reaches every patient. By addressing resource scarcity and systemic barriers, the Foundation works to bridge the gap between scientific discovery and patient delivery. ASGCT covers all operating costs so that 100% of every donation is directed to the ASGCT Foundation’s core priorities: supporting patients with rare and ultrarare diseases, empowering patient advocacy groups, and investing in early-career researchers.

Donate to the ASGCT Foundation

Our Mission

To ensure the future of gene and cell therapy by funding research and programming, leading to universal patient access.

Our Commitment

ASGCT covers all operating costs, ensuring that 100% of every donation is allocated directly to our core areas of immediate need:

Support for Rare & Ultrarare Disease Patients: Families facing rare diagnoses often battle geographic inequities and high costs. We fund infrastructure and programming that reduces barriers to diagnosis, treatment, and clinical trial participation.

Empowering Patient Advocacy Groups: Advocacy groups are the heart of drug development, yet many lack the funding and technical expertise to advance research. We provide the resources and infrastructure needed to close the gap in patient access.

Investing in Early Career Researchers: The future of the field depends on the next generation of scientists. As federal and private funding declines, we provide critical seed funding to promising researchers, ensuring innovative projects for rare diseases don't disappear.
 

By the Numbers

While the science of gene and cell therapy has seen extraordinary breakthroughs, the data reveals a significant gap between the potential for cures and the reality of patient access.

10,000+

Known Rare Diseases

30 Million

Americans Affected by Rare Disease

More to Explore

ASGCT Patient Education

The ASGCT Patient Education Program was initiated in January 2018 with the goal of making accurate, reliable, and accessible information about cell and gene therapies available to patients and the public.

Patient Press Newsletter

Stay up to date on news and events relevant to patients, caregivers, advocates, and anyone else affected by rare diseases with this bi-monthly publication.